tiprankstipranks
Trending News
More News >
MEDICLIN AG (GB:0NDG)
:0NDG

MEDICLIN (0NDG) Price & Analysis

Compare
0 Followers

0NDG Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.88%99.12%
Insiders
0.88%
Mutual Funds
― Other Institutional Investors
99.12% Public Companies and
Individual Investors

0NDG FAQ

What was MEDICLIN AG’s price range in the past 12 months?
MEDICLIN AG lowest share price was €2.36 and its highest was €5.25 in the past 12 months.
    What is MEDICLIN AG’s market cap?
    MEDICLIN AG’s market cap is €140.60M.
      When is MEDICLIN AG’s upcoming earnings report date?
      MEDICLIN AG’s upcoming earnings report date is Jul 31, 2025 which is in 52 days.
        How were MEDICLIN AG’s earnings last quarter?
        MEDICLIN AG released its earnings results on May 02, 2025. The company reported -€0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.003.
          Is MEDICLIN AG overvalued?
          According to Wall Street analysts MEDICLIN AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does MEDICLIN AG pay dividends?
            MEDICLIN AG pays a Notavailable dividend of €0.039 which represents an annual dividend yield of N/A. See more information on MEDICLIN AG dividends here
              What is MEDICLIN AG’s EPS estimate?
              MEDICLIN AG’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does MEDICLIN AG have?
              MEDICLIN AG has 47,500,000 shares outstanding.
                What happened to MEDICLIN AG’s price movement after its last earnings report?
                MEDICLIN AG reported an EPS of -€0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of MEDICLIN AG?
                  Currently, no hedge funds are holding shares in GB:0NDG

                  MEDICLIN Stock Smart Score

                  4
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  -44.00%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  12.45%
                  Trailing 12-Months
                  Asset Growth
                  -0.46%
                  Trailing 12-Months

                  Company Description

                  MEDICLIN AG

                  MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, surgery, nursing care, and others. The company also provides services in the areas of ENT and acute outpatient services. As of December 31, 2021, it owned 34 clinics, 7 nursing care facilities, and 11 medical care centres with a total capacity of 7,831 beds and 482 nursing places in 11 German federal states. The company is headquartered in Offenburg, Germany.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  RHON-KLINIKUM AG
                  MATERNUS-Kliniken AG
                  Limes Schlosskliniken AG
                  HAEMATO AG
                  M1 Kliniken AG
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis